Cargando…

A case of anti‐melanoma differentiation‐associated gene 5 antibody‐positive dermatomyositis‐associated rapidly progressive interstitial lung diseases developed after administration of COVID‐19 vaccine and subsequent pneumococcal vaccine

Five cases of anti‐melanoma differentiation‐associated gene 5 antibody‐positive dermatomyositis‐associated rapidly progressive interstitial lung diseases (anti‐MDA5‐positive DM‐RPILD) following COVID‐19 vaccination have been reported previously. We present the first case of the disease that develope...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi, Saeko, Kato, Ai, Hashimoto, Kanako, Takehara, Tomohiro, Ishioka, Kota, Takanashi, Satoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2022
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630759/ https://www.ncbi.nlm.nih.gov/pubmed/36348741 http://dx.doi.org/10.1002/rcr2.1064

Ejemplares similares

A case of disseminated intravascular coagulation following tumour lysis syndrome due to small cell carcinoma of the lung
por: Takahashi, Saeko, et al.
Publicado: (2023)

Use of High-Flow Nasal Cannula Oxygen Therapy in a Pregnant Woman with Dermatomyositis-Related Interstitial Pneumonia
por: Shoji, Tomohiro, et al.
Publicado: (2017)

COVID-19 vaccine-associated dermatomyositis
por: Wu, Marlyn, et al.
Publicado: (2022)

COVID-19 vaccine: Vaccine reaction, amyopathic dermatomyositis and interstitial lung disease: case report
Publicado: (2021)

Resistin Expression Is Associated With Interstitial Lung Disease in Dermatomyositis
por: Ye, Lifang, et al.
Publicado: (2022)

COVID-19 vaccine induced interstitial lung disease
por: Yoshifuji, Ayumi, et al.
Publicado: (2022)

Slowly progressive interstitial lung disease preceding typical dermatomyositis symptoms in anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis
por: Isono, Taisuke, et al.
Publicado: (2021)

Research progress on amyopathic dermatomyositis associated with interstitial lung disease
por: Bai, Yu, et al.
Publicado: (2020)

The association between antibody levels before and after 7-valent pneumococcal conjugate vaccine immunization and subsequent pneumococcal infection in chronic arthritis patients
por: Nagel, Johanna, et al.
Publicado: (2015)

Association of Pneumococcal Conjugate Vaccine Coverage With Pneumococcal Meningitis: An Analysis of French Administrative Areas, 2001–2016
por: Alari, Anna, et al.
Publicado: (2019)

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
por: Sugiyama, Yumiko, et al.
Publicado: (2018)

Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis
por: Palmucci, Stefano, et al.
Publicado: (2022)

Rituximab in the Treatment of Interstitial Lung Diseases Related to Anti-Melanoma Differentiation-Associated Gene 5 Dermatomyositis: A Systematic Review
por: He, Chenjia, et al.
Publicado: (2022)

A Case of Intravascular Diffuse Large B-Cell Lymphoma Initially Suspected as Interstitial Pneumonia Associated With Systemic Scleroderma
por: Oguri, Tomoyo, et al.
Publicado: (2021)

In-Hospital Pneumococcal Polysaccharide Vaccination Is Associated With Detection of Pneumococcal Vaccine Serotypes in Adults Hospitalized for Community-Acquired Pneumonia
por: Grijalva, Carlos G., et al.
Publicado: (2015)

Rituximab in Antimelanoma Differentiation-Associated Protein-5 Dermatomyositis with Interstitial Lung Disease
por: Scirocco, Chiara, et al.
Publicado: (2020)

Clinical nomogram assisting in discrimination of juvenile dermatomyositis-associated interstitial lung disease
por: Hu, Minfei, et al.
Publicado: (2023)

Predictors of rapidly progressive interstitial lung disease and prognosis in Chinese patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis
por: Li, Meiqi, et al.
Publicado: (2023)

Recent Topics of Pneumococcal Vaccination: Indication of Pneumococcal Vaccine for Individuals at a Risk of Pneumococcal Disease in Adults
por: Asai, Nobuhiro, et al.
Publicado: (2021)

Global Control of Pneumococcal Infections by Pneumococcal Vaccines
por: Oishi, Kazunori, et al.
Publicado: (2014)

Pneumococcal disease and use of pneumococcal vaccines in Taiwan
por: Wei, Sung-Hsi, et al.
Publicado: (2015)

Pneumococcal conjugate vaccination schedules in infants—acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study
por: Mackenzie, Grant A., et al.
Publicado: (2022)

A RAPIDLY PROGRESSIVE AND RARE ILLNESS: AUTOANTIBODIES AGAINST MELANOMA DIFFERENTIATION-ASSOCIATED PROTEIN 5 (ANTI-MDA5): AMYOPATHIC DERMATOMYOSITIS WITH PROGRESSIVE INTERSTITIAL LUNG DISEASE THAT DEVELOPED AFTER COVID-19 VACCINE
por: CARRASCO, LEONEL, et al.
Publicado: (2021)

Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination
por: van den Biggelaar, Anita H. J., et al.
Publicado: (2017)

Non‐specific interstitial pneumonia associated with clinically amyopathic dermatomyositis showing “crazy paving” appearance on thin‐section lung CT
por: Aono, Yuya, et al.
Publicado: (2018)

Small cell lung cancer and interstitial pneumonia associated with anti‐transcriptional intermediary factor‐1γ‐positive dermatomyositis
por: Kato, Toshio, et al.
Publicado: (2019)

Pirfenidone in patients with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis
por: Li, Ting, et al.
Publicado: (2016)

Adrenomedullin Expression Is Associated With the Severity and Poor Prognosis of Interstitial Lung Disease in Dermatomyositis Patients
por: Ye, Lifang, et al.
Publicado: (2022)

Risk Factors and Predictive Model for Dermatomyositis Associated with Rapidly Progressive Interstitial Lung Disease
por: Wang, Kai, et al.
Publicado: (2022)

Blood purification in two patients with clinically amyopathic dermatomyositis associated with interstitial lung disease with anti-melanoma differentiation-associated gene-5 antibody (MDA-5)
por: Shi, Han-yu, et al.
Publicado: (2019)

Prediction model for the pretreatment evaluation of mortality risk in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with interstitial lung disease
por: Gui, Xianhua, et al.
Publicado: (2022)

Anti–melanoma differentiation–associated gene 5 dermatomyositis complicated by myopericarditis
por: Milani-Nejad, Nima, et al.
Publicado: (2019)

An unusual anti–melanoma differentiation–associated protein 5 amyopathic dermatomyositis
por: Barailler, Héloïse, et al.
Publicado: (2019)

Decrease in Pneumococcal Co-Colonization following Vaccination with the Seven-Valent Pneumococcal Conjugate Vaccine
por: Valente, Carina, et al.
Publicado: (2012)

Effect of Age and Vaccination With a Pneumococcal Conjugate Vaccine on the Density of Pneumococcal Nasopharyngeal Carriage
por: Roca, A., et al.
Publicado: (2012)

Pneumococcal Conjugate Vaccination Followed by Pneumococcal Polysaccharide Vaccination in Lung Transplant Candidates and Recipients
por: Hoffman, Thijs W., et al.
Publicado: (2020)

Frequency-dependent selection in vaccine-associated pneumococcal population dynamics
por: Corander, Jukka, et al.
Publicado: (2017)

Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations
por: Naucler, Pontus, et al.
Publicado: (2017)

Post-Vaccine Evaluation to Assist with Subsequent COVID-19 Vaccine Administration
por: Rosenblum, Jake, et al.
Publicado: (2023)

Roles of biomarkers in anti‐MDA5‐positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease
por: Li, Xiaomeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3ml3hetrtdbssnirunm5ohtd8r